Retraction-Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.
机构信息
The Lancet, London EC2Y 5AS, UK.
出版信息
Lancet. 2019 Mar 16;393(10176):1084. doi: 10.1016/S0140-6736(19)30542-2. Epub 2019 Mar 14.
Abstract
摘要
相似文献
1
Retraction-Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.撤稿——缺血性心肌病患者的心脏干细胞（SCIPIO）：一项随机1期试验的初步结果。
Lancet. 2019 Mar 16;393(10176):1084. doi: 10.1016/S0140-6736(19)30542-2. Epub 2019 Mar 14.
2
[Treatment of cardiac insufficiency: does treatment depend on whether its cause is ischemic or idiopathic?].[心脏功能不全的治疗：治疗是否取决于其病因是缺血性还是特发性？]
Arch Mal Coeur Vaiss. 1999 Jun;92(6):727-32.
3
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.Ixmyelocel-T 治疗缺血性心力衰竭患者的前瞻性随机双盲试验。
Lancet. 2016 Jun 11;387(10036):2412-21. doi: 10.1016/S0140-6736(16)30137-4. Epub 2016 Apr 5.
4
Implantable cardiac defibrillator and mortality in non-ischaemic cardiomyopathy: an updated meta-analysis.可植入式心脏除颤器与非缺血性心肌病患者的死亡率：一项更新的荟萃分析。
Heart. 2018 Feb;104(3):230-236. doi: 10.1136/heartjnl-2017-311430. Epub 2017 Aug 5.
5
Antithrombotic drugs and ischaemic stroke.抗血栓药物与缺血性中风
Prescrire Int. 2013 Nov;22(143):270-1.
6
Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial.细胞因子联合成人自体骨髓祖细胞治疗非缺血性扩张型心肌病患者的随机试验：再生-DCM临床试验
Eur Heart J. 2015 Nov 21;36(44):3061-9. doi: 10.1093/eurheartj/ehv390. Epub 2015 Sep 2.
7
Pentoxifylline for heart failure: a systematic review.己酮可可碱治疗心力衰竭：一项系统评价。
S Afr Med J. 2005 Mar;95(3):171-5.
8
Differences in predictors of implantable cardioverter-defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies.缺血性和非缺血性心肌病患者植入式心脏复律除颤器治疗预测因素的差异。
Europace. 2016 Mar;18(3):405-12. doi: 10.1093/europace/euv138. Epub 2015 Jun 7.
9
High spatial resolution free-breathing 3D late gadolinium enhancement cardiac magnetic resonance imaging in ischaemic and non-ischaemic cardiomyopathy: quantitative assessment of scar mass and image quality.高空间分辨率自由呼吸 3D 晚期钆增强心脏磁共振成像在缺血性和非缺血性心肌病中的应用：瘢痕质量和图像质量的定量评估。
Eur Radiol. 2018 Sep;28(9):4027-4035. doi: 10.1007/s00330-018-5361-y. Epub 2018 Apr 6.
10
Comparison of the Effect of Sacubitril/Valsartan on Left Ventricular Systolic Function in Patients with Non-ischaemic and Ischaemic Cardiomyopathy.比较沙库巴曲缬沙坦对非缺血性和缺血性心肌病患者左心室收缩功能的影响。
Cardiovasc Drugs Ther. 2020 Dec;34(6):755-762. doi: 10.1007/s10557-020-07036-3. Epub 2020 Jul 9.
引用本文的文献
1
Injectable Stem Cell-Based Therapies for Myocardial Regeneration: A Review of the Literature.用于心肌再生的基于干细胞的注射疗法：文献综述
J Funct Biomater. 2025 Apr 23;16(5):152. doi: 10.3390/jfb16050152.
2
Cardiac progenitor cell therapy: mechanisms of action.心脏祖细胞疗法：作用机制
Cell Biosci. 2024 Mar 5;14(1):30. doi: 10.1186/s13578-024-01211-x.
3
Who Should Be Accountable for Scientific Accountability?谁应该对科学问责负责？
JACC Basic Transl Sci. 2023 Aug 28;8(8):1040-1042. doi: 10.1016/j.jacbts.2023.08.001. eCollection 2023 Aug.
4
Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments.通过下一代治疗方法释放再生疗法在心力衰竭中的实用潜力。
Biomedicines. 2023 Mar 15;11(3):915. doi: 10.3390/biomedicines11030915.
5
The Progress of Stem Cell Therapy in Myocardial-Infarcted Heart Regeneration: Cell Sheet Technology.干细胞治疗在心肌梗死心脏再生中的进展：细胞片层技术。
Tissue Eng Regen Med. 2022 Oct;19(5):969-986. doi: 10.1007/s13770-022-00467-z. Epub 2022 Jul 20.
6
Myocardial regeneration protocols towards the routine clinical scenario: An unseemly path from bench to bedside.面向常规临床应用的心肌再生方案：从实验室到临床的艰难之路。
EClinicalMedicine. 2022 Jun 27;50:101530. doi: 10.1016/j.eclinm.2022.101530. eCollection 2022 Aug.
7
Cardiac regeneration following myocardial infarction: the need for regeneration and a review of cardiac stromal cell populations used for transplantation.心肌梗死后的心脏再生：再生的必要性以及用于移植的心脏基质细胞群体综述。
Biochem Soc Trans. 2022 Feb 28;50(1):269-281. doi: 10.1042/BST20210231.
8
Fake It Till You Make It: What Every Translational Investigator Can Learn From the Rise and Fall of Theranos.假装成功直到真的成功：每位转化医学研究者能从Theranos的兴衰中学到什么。
JACC Basic Transl Sci. 2022 Jan 5;7(1):99-100. doi: 10.1016/j.jacbts.2021.12.004. eCollection 2022 Jan.
9
[Cardiac cell therapy-Lost in translation?].[心脏细胞治疗——翻译不当？]
Z Herz Thorax Gefasschir. 2022;36(2):107-114. doi: 10.1007/s00398-021-00476-5. Epub 2022 Jan 5.
10
Cell therapy in patients with heart failure: a comprehensive review and emerging concepts.心力衰竭患者的细胞治疗：全面综述与新兴概念。
Cardiovasc Res. 2022 Mar 16;118(4):951-976. doi: 10.1093/cvr/cvab135.
本文引用的文献
1
Expression of concern: the SCIPIO trial.关注声明：SCIPIO试验。
Lancet. 2014 Apr 12;383(9925):1279. doi: 10.1016/S0140-6736(14)60608-5.
2
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.缺血性心肌病患者的心脏干细胞（SCIPIO）：一项随机 1 期试验的初步结果。
Lancet. 2011 Nov 26;378(9806):1847-57. doi: 10.1016/S0140-6736(11)61590-0. Epub 2011 Nov 14.
Zotero 插件